Charles River Laboratories Stock EBITDA

CRL Stock

USD 195.77 1.58 0.81%

Charles River Laboratories fundamentals help investors to digest information that contributes to Charles River's financial success or failures. It also enables traders to predict the movement of Charles Stock. The fundamental analysis module provides a way to measure Charles River's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Charles River stock.

		Last Reported	Projected for Next Year
	EBITDA	1 B	1.1 B

EBITDA is expected to rise to about 1.1 B this year.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Charles River Laboratories Company EBITDA Analysis

Charles River's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Charles River EBITDA

1.03 B

Most of Charles River's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Charles River Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Charles EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Charles River is extremely important. It helps to project a fair market value of Charles Stock properly, considering its historical fundamentals such as EBITDA. Since Charles River's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Charles River's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Charles River's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets	Long Term Debt	Good Will	Property Plant Equipment	Short Term Investments	Treasury Stock	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.98	0.99	0.93	0.97	0.98	0.99	0.99	0.66	-0.19	0.86	0.99	1.0	0.97	-0.51	0.65	-0.9	0.99	-0.65	0.96	0.89	-0.7	0.92	0.94	0.2	0.86
Total Stockholder Equity	0.99		0.95	0.97	0.96	0.94	0.96	0.97	0.98	0.75	-0.2	0.79	0.96	0.99	0.98	-0.5	0.65	-0.83	0.98	-0.64	0.94	0.87	-0.72	0.89	0.94	0.31	0.91
Current Deferred Revenue	0.98	0.95		0.98	0.9	0.97	0.98	0.99	0.97	0.56	-0.23	0.9	0.99	0.98	0.92	-0.52	0.66	-0.92	0.97	-0.63	0.97	0.92	-0.62	0.92	0.92	0.13	0.8
Net Debt	0.99	0.97	0.98		0.9	0.98	0.98	1.0	0.98	0.6	-0.18	0.89	1.0	0.99	0.96	-0.53	0.65	-0.93	0.98	-0.65	0.96	0.9	-0.7	0.91	0.94	0.13	0.83
Retained Earnings	0.93	0.96	0.9	0.9		0.89	0.89	0.89	0.9	0.76	-0.3	0.71	0.89	0.94	0.92	-0.42	0.62	-0.76	0.95	-0.52	0.88	0.82	-0.77	0.81	0.9	0.38	0.9
Accounts Payable	0.97	0.94	0.97	0.98	0.89		0.95	0.98	0.94	0.51	-0.22	0.9	0.98	0.97	0.92	-0.49	0.63	-0.92	0.95	-0.58	0.94	0.92	-0.71	0.9	0.94	0.04	0.79
Net Receivables	0.98	0.96	0.98	0.98	0.89	0.95		0.99	0.99	0.62	-0.11	0.87	0.98	0.97	0.94	-0.44	0.59	-0.9	0.96	-0.6	0.96	0.88	-0.62	0.91	0.9	0.2	0.81
Total Liab	0.99	0.97	0.99	1.0	0.89	0.98	0.99		0.98	0.59	-0.18	0.9	1.0	0.99	0.95	-0.52	0.65	-0.93	0.98	-0.65	0.97	0.9	-0.67	0.92	0.93	0.12	0.82
Total Current Assets	0.99	0.98	0.97	0.98	0.9	0.94	0.99	0.98		0.68	-0.09	0.83	0.97	0.97	0.96	-0.43	0.58	-0.86	0.96	-0.61	0.95	0.86	-0.64	0.9	0.9	0.24	0.84
Short Term Debt	0.66	0.75	0.56	0.6	0.76	0.51	0.62	0.59	0.68		-0.03	0.25	0.57	0.66	0.76	-0.32	0.36	-0.36	0.67	-0.41	0.56	0.4	-0.56	0.5	0.6	0.69	0.81
Common Stock	-0.19	-0.2	-0.23	-0.18	-0.3	-0.22	-0.11	-0.18	-0.09	-0.03		-0.3	-0.2	-0.26	-0.06	0.55	-0.81	0.25	-0.29	0.61	-0.31	-0.36	0.06	-0.39	-0.36	0.03	-0.17
Intangible Assets	0.86	0.79	0.9	0.89	0.71	0.9	0.87	0.9	0.83	0.25	-0.3		0.9	0.86	0.74	-0.49	0.65	-0.95	0.84	-0.62	0.91	0.91	-0.5	0.91	0.87	-0.06	0.51
Long Term Debt	0.99	0.96	0.99	1.0	0.89	0.98	0.98	1.0	0.97	0.57	-0.2	0.9		0.99	0.94	-0.53	0.66	-0.95	0.98	-0.66	0.97	0.89	-0.68	0.92	0.93	0.1	0.81
Good Will	1.0	0.99	0.98	0.99	0.94	0.97	0.97	0.99	0.97	0.66	-0.26	0.86	0.99		0.96	-0.53	0.69	-0.9	1.0	-0.66	0.97	0.89	-0.73	0.91	0.95	0.19	0.87
Property Plant Equipment	0.97	0.98	0.92	0.96	0.92	0.92	0.94	0.95	0.96	0.76	-0.06	0.74	0.94	0.96		-0.47	0.55	-0.8	0.95	-0.57	0.88	0.82	-0.77	0.82	0.91	0.32	0.89
Short Term Investments	-0.51	-0.5	-0.52	-0.53	-0.42	-0.49	-0.44	-0.52	-0.43	-0.32	0.55	-0.49	-0.53	-0.53	-0.47		-0.79	0.52	-0.55	0.8	-0.52	-0.52	0.22	-0.54	-0.58	-0.01	-0.45
Treasury Stock	0.65	0.65	0.66	0.65	0.62	0.63	0.59	0.65	0.58	0.36	-0.81	0.65	0.66	0.69	0.55	-0.79		-0.64	0.71	-0.93	0.73	0.7	-0.31	0.78	0.73	0.01	0.57
Net Tangible Assets	-0.9	-0.83	-0.92	-0.93	-0.76	-0.92	-0.9	-0.93	-0.86	-0.36	0.25	-0.95	-0.95	-0.9	-0.8	0.52	-0.64		-0.9	0.62	-0.93	-0.82	0.6	-0.89	-0.84	0.1	-0.63
Long Term Debt Total	0.99	0.98	0.97	0.98	0.95	0.95	0.96	0.98	0.96	0.67	-0.29	0.84	0.98	1.0	0.95	-0.55	0.71	-0.9		-0.68	0.96	0.87	-0.72	0.91	0.94	0.21	0.87
Capital Surpluse	-0.65	-0.64	-0.63	-0.65	-0.52	-0.58	-0.6	-0.65	-0.61	-0.41	0.61	-0.62	-0.66	-0.66	-0.57	0.8	-0.93	0.62	-0.68		-0.72	-0.62	0.22	-0.78	-0.68	-0.03	-0.53
Deferred Long Term Liab	0.96	0.94	0.97	0.96	0.88	0.94	0.96	0.97	0.95	0.56	-0.31	0.91	0.97	0.97	0.88	-0.52	0.73	-0.93	0.96	-0.72		0.89	-0.57	0.96	0.91	0.1	0.79
Long Term Investments	0.89	0.87	0.92	0.9	0.82	0.92	0.88	0.9	0.86	0.4	-0.36	0.91	0.89	0.89	0.82	-0.52	0.7	-0.82	0.87	-0.62	0.89		-0.55	0.9	0.94	0.14	0.65
Short Long Term Debt	-0.7	-0.72	-0.62	-0.7	-0.77	-0.71	-0.62	-0.67	-0.64	-0.56	0.06	-0.5	-0.68	-0.73	-0.77	0.22	-0.31	0.6	-0.72	0.22	-0.57	-0.55		-0.48	-0.72	-0.21	-0.7
Cash And Equivalents	0.92	0.89	0.92	0.91	0.81	0.9	0.91	0.92	0.9	0.5	-0.39	0.91	0.92	0.91	0.82	-0.54	0.78	-0.89	0.91	-0.78	0.96	0.9	-0.48		0.91	0.13	0.67
Net Invested Capital	0.94	0.94	0.92	0.94	0.9	0.94	0.9	0.93	0.9	0.6	-0.36	0.87	0.93	0.95	0.91	-0.58	0.73	-0.84	0.94	-0.68	0.91	0.94	-0.72	0.91		0.26	0.77
Net Working Capital	0.2	0.31	0.13	0.13	0.38	0.04	0.2	0.12	0.24	0.69	0.03	-0.06	0.1	0.19	0.32	-0.01	0.01	0.1	0.21	-0.03	0.1	0.14	-0.21	0.13	0.26		0.26
Capital Stock	0.86	0.91	0.8	0.83	0.9	0.79	0.81	0.82	0.84	0.81	-0.17	0.51	0.81	0.87	0.89	-0.45	0.57	-0.63	0.87	-0.53	0.79	0.65	-0.7	0.67	0.77	0.26

Click cells to compare fundamentals

Charles EBITDA Historical Pattern

Today, most investors in Charles River Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Charles River's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Charles River ebitda as a starting point in their analysis.

Charles River EBITDA

Timeline

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Charles River

Ebitda Over Time

Charles Ebitda

Ebitda

1.08 Billion

At this time, Charles River's EBITDA is quite stable compared to the past year.

According to the company disclosure, Charles River Laboratories reported earnings before interest,tax, depreciation and amortization of 1.03 B. This is 17.63% higher than that of the Life Sciences Tools & Services sector and 197.52% higher than that of the Health Care industry. The ebitda for all United States stocks is 73.53% higher than that of the company.

Charles EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Charles River's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Charles River could also be used in its relative valuation, which is a method of valuing Charles River by comparing valuation metrics of similar companies.

Charles River is currently under evaluation in ebitda category among its peers.

Charles River ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Charles River's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Charles River's managers, analysts, and investors.

Environmental

Governance

Social

Charles River Institutional Holders

Institutional Holdings refers to the ownership stake in Charles River that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Charles River's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Charles River's value.

		Shares
Bank Of America Corp	2024-06-30	974.7 K
Mackenzie Investments	2024-09-30	971.3 K
Morgan Stanley - Brokerage Accounts	2024-06-30	963.5 K
Ariel Investments, Llc	2024-09-30	897.7 K
Marshall Wace Asset Management Ltd	2024-06-30	825.9 K
Southpoint Capital Advisors Lp	2024-09-30	670 K
Franklin Resources Inc	2024-09-30	664.5 K
T. Rowe Price Associates, Inc.	2024-06-30	641 K
Sei Investments Co	2024-06-30	624.8 K
Vanguard Group Inc	2024-09-30	6.1 M
Blackrock Inc	2024-06-30	5.1 M

Charles Fundamentals

	Return On Equity	0.12
	Return On Asset	0.0487
	Profit Margin	0.10 %
	Operating Margin	0.15 %
	Current Valuation	12.56 B
	Shares Outstanding	51.14 M
	Shares Owned By Insiders	0.92 %
	Shares Owned By Institutions	99.08 %
	Number Of Shares Shorted	1.85 M
	Price To Earning	33.74 X
	Price To Book	2.65 X
	Price To Sales	2.47 X
	Revenue	4.13 B
	Gross Profit	1.46 B
	EBITDA	1.03 B
	Net Income	480.37 M
	Cash And Equivalents	233.91 M
	Cash Per Share	3.96 X
	Total Debt	3.07 B
	Debt To Equity	1.27 %
	Current Ratio	1.33 X
	Book Value Per Share	73.97 X
	Cash Flow From Operations	683.9 M
	Short Ratio	2.73 X
	Earnings Per Share	8.01 X
	Price To Earnings To Growth	2.52 X
	Target Price	217.01
	Number Of Employees	20.4 K
	Beta	1.38
	Market Capitalization	10.01 B
	Total Asset	8.2 B
	Retained Earnings	1.89 B
	Working Capital	553.58 M
	Current Asset	559.23 M
	Current Liabilities	311.76 M
	Net Asset	8.2 B

About Charles River Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Charles River Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Charles River using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Charles River Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Charles River Labora is a strong investment it is important to analyze Charles River's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Charles River's future performance. For an informed investment choice regarding Charles Stock, refer to the following important reports:

How To Invest In Charles

Details

Is Charles Stock a good investment?

Details

What is Charles River's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Charles River Piotroski F Score and Charles River Altman Z Score analysis.

You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charles River. If investors know Charles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Charles River listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.21)

Earnings Share

8.01

Revenue Per Share

78.97

Quarterly Revenue Growth

(0.02)

Return On Assets

0.0487

The market value of Charles River Labora is measured differently than its book value, which is the value of Charles that is recorded on the company's balance sheet. Investors also form their own opinion of Charles River's value that differs from its market value or its book value, called intrinsic value, which is Charles River's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Charles River's market value can be influenced by many factors that don't directly affect Charles River's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Charles River's value and its price as these two are different measures arrived at by different means. Investors typically determine if Charles River is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Charles River's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Charles River Laboratories Stock EBITDA

Charles River Laboratories Company EBITDA Analysis

EBITDA

Revenue

-

Basic Expenses

Current Charles River EBITDA

Charles EBITDA Driver Correlations

Charles EBITDA Historical Pattern

Charles Ebitda

Ebitda

1.08 Billion

Charles EBITDA Peer Comparison

Charles River ESG Sustainability

Charles River Institutional Holders

Charles Fundamentals

About Charles River Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY